CoChat
Sign Up
Cited by 24

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method

Teschke, Rolf·2018·Expert Opinion on Drug Metabolism & Toxicology
DOI 10.1080/17425255.2018.1539077
Open this paper in CoChat — free account

Abstract

Introduction A list presenting a valid ranking of drugs most commonly implicated is hardly to be found. Areas covered: Published cases of drug-induced liver injury (DILI) with verified causality using RUCAM (Roussel Uclaf Causality Assessment Method) were used for a ranking of drugs most commonly implicated in causing DILI. Expert opinion: RUCAM-based DILI cases were retrieved from 15 reports published by six international databases of DILI registries and three large medical centers, which provided 3312 cases. Overall 48 drugs with the highest number of DILI cases were listed. Among the top 10 ranking drugs implicated in causing DILI were, in decreasing order: amoxicillin-clavulanate, flucloxacilllin, atorvastatin, disulfiram, diclofenac, simvastatin, carbamazepine, ibuprofen, erythromycin, and anabolic steroids as bodybuilding agents. For these 10 drugs, respective DILI case numbers were highest for Amoxicillin-clavulanate (n=333) and lowest for anabolic steroids (n=26). The author classifies the databases of national DILI registries and large medical centers as best sources of drugs implicated in DILI. Presently discouraged is the use of the LiverTox website because many cases were derived from published cases of poor quality and could previously not be classified as DILI, calling for the inclusion of DILI cases with established causality by the updated RUCAM.

Overview

Integrity signals

Registry

Crossref · 10.1080/17425255.2018.1539077

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 81

  1. Sarges P, 2016, Drug Saf, 39, 561, 10.1007/s40264-016-0427-8 · DOI · Paper page
  2. 10.1080/17425255.2017.1362391 · DOI · Paper page
  3. Teschke R, 2018, Clin Diagn Pathol, 2, 1
  4. 10.1111/liv.12836 · DOI
  5. 10.4254/wjh.v9.i1.30 · DOI
  6. 10.3390/ijms18040803 · DOI
  7. 10.3390/ijms17020224 · DOI · Paper page
  8. 10.1111/bcp.13593 · DOI
  9. 10.1136/gut.44.5.731 · DOI
  10. 10.1136/bmj.319.7224.1541 · DOI
  11. 10.1016/0895-4356(93)90101-6 · DOI · Paper page
  12. 10.1016/0895-4356(93)90102-7 · DOI · Paper page
  13. 10.3390/ijms17010014 · DOI · Paper page
  14. 10.1007/s40264-018-0654-2 · DOI · Paper page
  15. 10.1002/hep.20800 · DOI · Paper page
  16. 10.1016/j.gastro.2005.05.006 · DOI · Paper page
  17. Wai CT, 2006, Singapore Med J, 47, 116
  18. 10.1002/hep.21424 · DOI · Paper page
  19. 10.1111/j.1365-2036.2008.03655.x · DOI · Paper page
  20. 10.1038/ajg.2010.287 · DOI · Paper page
  21. 10.1053/j.gastro.2011.04.001 · DOI · Paper page
  22. 10.1016/j.jhep.2011.07.023 · DOI
  23. 10.1371/journal.pone.0068111 · DOI
  24. Douros A, 2014, Br J Clin Pharmacol, 79, 988, 10.1111/bcp.12565 · DOI
  25. Robles-Diaz M, 2015, Aliment Pharmacol Ther, 41, 116, 10.1111/apt.13023 · DOI · Paper page
  26. 10.1111/jgh.13323 · DOI · Paper page
  27. Rathi C, 2017, Ann Hepatol, 16, 442, 10.5604/01.3001.0009.8600 · DOI · Paper page
  28. Yoon E, 2016, J Clin Transl Hepatol, 28, 131
  29. 10.3390/ijms18051018 · DOI
  30. 10.2174/092986709788803097 · DOI
  31. 10.1038/clpt.2011.58 · DOI · Paper page
  32. 10.1007/978-1-4939-7677-5_27 · DOI · Paper page
  33. Teschke R, 201, New approach of liver diseases: mechanism and management
  34. Teschke R, 2014, Ann Hepatol, 13, 248, 10.1016/S1665-2681(19)30888-9 · DOI
  35. 10.1053/jhep.2001.20645 · DOI · Paper page
  36. 10.1053/jhep.2002.34857 · DOI · Paper page
  37. 10.1111/j.1365-2036.2006.03117.x · DOI · Paper page
  38. 10.1002/pds.3531 · DOI
  39. 10.4254/wjh.v5.i7.353 · DOI
  40. 10.1016/j.dld.2013.10.020 · DOI
  41. Teschke R, 2015, J Liver Clin Res, 2, 1008
  42. 10.1007/s40264-016-0423-z · DOI
  43. 10.1080/17425255.2017.1252749 · DOI
  44. 10.1002/hep.22322 · DOI · Paper page
  45. Teschke R, 2014, Ann Hepatol, 13, 121, 10.1016/S1665-2681(19)30913-5 · DOI
  46. Teschke R, 2015, J Liver Clin Res, 2, 1013
  47. 10.5604/16652681.1184237 · DOI · Paper page
  48. 10.3390/ijms17040476 · DOI · Paper page
  49. Teschke R, 2017, Dig Dis Sci, 62, 1095, 10.1007/s10620-016-4442-5 · DOI
  50. Willson C, 2018, Int J Med Res Health Sci, 7, 10
  51. Willson C, 2018, Int J Med Res Health Sci, 7, 162
  52. 10.1080/15598608.2017.1305923 · DOI
  53. Teschke R, 2018, J Gastroenterol Hepatol Open, 2, 152
  54. Roytman MA, 2018, Clin Pharmacol Ther, 104, 10.1002/cpt.1097 · DOI
  55. 10.1007/s12072-017-9793-2 · DOI · Paper page
  56. 10.14218/JCTH.2017.00033 · DOI
  57. 10.1053/j.gastro.2015.04.027 · DOI
  58. Teschke R, 2017, Ann Hepatol, 16, 324, 10.5604/16652681.1235471 · DOI · Paper page
  59. 10.1002/hep.28323 · DOI · Paper page
  60. 10.1517/17425250903018904 · DOI
  61. 10.1097/gme.0b013e31816054bf · DOI
  62. 10.1002/pds.2127 · DOI
  63. 10.1097/gme.0b013e3181fcb2a6 · DOI
  64. 10.1002/pds.3209 · DOI
  65. 10.1007/BF03261996 · DOI
  66. 10.1007/s10620-016-4181-7 · DOI
  67. 10.1053/j.gastro.2013.12.032 · DOI
  68. Shi Q, 2014, Expert Rev Gastroenterol Hepatol, 4, 225, 10.1586/egh.10.8 · DOI
  69. 10.1111/liv.12384 · DOI
  70. 10.1016/j.cgh.2015.06.017 · DOI
  71. 10.3390/jcm4051063 · DOI
  72. Zheng J, 2015, Front Pharmacol, 6, 236, 10.3389/fphar.2015.00236 · DOI
  73. 10.3390/ijms151017644 · DOI
  74. Li LM, 2014, Clin Transl Hepatol, 2, 162
  75. Yang X, 2012, Curr Biomarker Find, 20, 43
  76. 10.1002/hep.24538 · DOI
  77. 10.1111/liv.12322 · DOI
  78. 10.1371/journal.pone.0037395 · DOI
  79. Teschke R, 2017, AME Med J, 2, 144, 10.21037/amj.2017.09.05 · DOI
  80. 10.1007/s40495-018-0124-7 · DOI · Paper page
  81. 10.3390/medicines3030018 · DOI · Paper page

Cited by

Sorted by citations

See all 24

Metadata

Authors
Teschke, R.
Affiliations
Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Hanau, Germany
Venue
Expert Opinion on Drug Metabolism & Toxicology
Publisher
Informa UK Limited
Published
2018-10-25
Pages
1-19
ISSN
  • 1742-5255
  • 1744-7607
DOI
10.1080/17425255.2018.1539077
Cited by
24
References
1
Language
en
Funders
not funded

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review